CBD and CBG modified melanoma cell membrane composition, lipid signaling, and cannabinoid receptor expression — effects enhanced by UVA radiation, suggesting potential for integrative melanoma therapy.
Melanoma researchers, cancer biologists, and scientists studying cannabinoid anti-cancer mechanisms
What the researchers found
CBD (5 µM) and CBG (1 µM) altered melanoma cell membrane phospholipid fatty acids, sialic acid, surface charge, and lipid rafts; increased endocannabinoid 2-AG levels; and when combined, reduced pro-inflammatory eicosanoids and modified cannabinoid receptor expression after UVA irradiation.
Why it matters
Melanoma has high metastatic potential and poor prognosis in advanced stages — finding that phytocannabinoids target cell membrane structures important for metastasis opens a novel therapeutic angle.
The numbers in context
CBD at 5 µM, CBG at 1 µM; UVA dose 18 J/cm²; combined CBD/CBG reduced pro-inflammatory eicosanoids; significant 2-AG increase with phytocannabinoid treatment; altered CB1/CB2/TRPV1/PPARγ expression.
How the study worked
In vitro study of CBD and CBG effects on SK-MEL-5 melanoma cells, analyzing membrane composition, lipolytic enzyme activity, lipid mediators, and receptor expression with and without UVA irradiation.
What this study cannot tell us
Single cell line in vitro; concentrations may not be achievable in vivo; UVA irradiation model may not reflect all melanoma contexts; no cell viability or tumor growth data.
How to read the evidence
Detailed mechanistic in vitro study with comprehensive lipid analysis, but single cell line and no functional anti-cancer endpoints measured.
When this study was published
Published in 2026, contributing to the growing understanding of phytocannabinoid anti-cancer mechanisms.
The bigger picture
Cell membranes are increasingly recognized as therapeutic targets in cancer — phytocannabinoids' ability to remodel membrane composition and lipid signaling adds a mechanistic dimension to their anticancer potential.
Questions still open
- Can membrane-targeted phytocannabinoid effects translate to anti-metastatic outcomes in vivo? Would these effects occur in other melanoma cell lines or cancer types?
Common questions
Can cannabinoids help treat melanoma?
What is CBG?
Read the original research
Phytocannabinoids influence phospholipid metabolism of melanoma cells: Modulation of in vitro effects of the UVA irradiation.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 195, 119003
Citation
Biernacki, Michał; Sękowski, Szymon; Dobrzyńska, Izabela; Olchowik-Grabarek, Ewa; Zarkovic, Neven; Jarocka-Karpowicz, Iwona; Gęgotek, Agnieszka; Skrzydlewska, Elżbieta. (2026). Phytocannabinoids influence phospholipid metabolism of melanoma cells: Modulation of in vitro effects of the UVA irradiation.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 195, 119003. https://doi.org/10.1016/j.biopha.2026.119003
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk